Title

Reply to "Subcutaneous terbutaline as an alternative to aerosolized albuterol".

Document Type

Response or Comment

Publication Date

7-2020

Identifier

DOI: 10.1016/j.jaip.2020.04.016; PMCID: PMC7174169

Abstract

Comment on

Journal Title

J Allergy Clin Immunol Pract

Volume

8

Issue

7

First Page

2450

Last Page

2452

MeSH Keywords

Albuterol; COVID-19; Humans; Hypersensitivity; Pandemics; SARS-CoV-2; Terbutaline

Keywords

Albuterol; COVID-19; Humans; Hypersensitivity; Pandemics; SARS-CoV-2; Terbutaline

Library Record

Share

COinS